Drug resistance mechanisms and drug susceptibility testing for tuberculosis
|
|
September 2018 |
Mycobacterium tuberculosis : success through dormancy
|
|
May 2012 |
Mycobacterium tuberculosis Antigen 85A and 85C Structures Confirm Binding Orientation and Conserved Substrate Specificity
|
|
June 2004 |
Role of the Major Antigen of Mycobacterium tuberculosis in Cell Wall Biogenesis
|
|
May 1997 |
Inactivation of the Mycobacterium tuberculosis Antigen 85 Complex by Covalent, Allosteric Inhibitors
|
|
July 2014 |
The Three Mycobacterium tuberculosis Antigen 85 Isoforms Have Unique Substrates and Activities Determined by Non-active Site Regions
|
|
July 2014 |
Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope
|
|
March 1999 |
Disruption of the Genes Encoding Antigen 85A and Antigen 85B of Mycobacterium tuberculosis H37Rv: Effect on Growth in Culture and in Macrophages
|
|
February 2000 |
Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity.
|
|
January 1987 |
Orlistat, a New Lipase Inhibitor for the Management of Obesity
|
|
March 2000 |
Synthesis of Long‐Chain β‐Lactones and Their Antibacterial Activities against Pathogenic Mycobacteria
|
|
January 2019 |
The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds
|
|
January 2004 |
Mycobacterium tuberculosis Rv3802c Encodes a Phospholipase/Thioesterase and Is Inhibited by the Antimycobacterial Agent Tetrahydrolipstatin
|
|
January 2009 |
Identification and structural characterization of an unusual mycobacterial monomeromycolyl-diacylglycerol: Characterization of a mycobacterial monomeromycolyl-diacylglycerol
|
|
July 2005 |
Small-Molecule Probes Reveal Esterases with Persistent Activity in Dormant and Reactivating Mycobacterium tuberculosis
|
|
October 2016 |
Characterization of Tetrahydrolipstatin and Stereoderivatives on the Inhibition of Essential Mycobacterium tuberculosis Lipid Esterases
|
|
March 2018 |
The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase
|
|
February 1991 |
Syntheses of Tetrahydrolipstatin and Absolute Configuration of Tetrahydrolipstatin and Lipstatin
|
|
February 1987 |
A Stereochemical Model for Merged 1,2- and 1,3-Asymmetric Induction in Diastereoselective Mukaiyama Aldol Addition Reactions and Related Processes
|
|
January 1996 |
Stereochemical Structure Activity Relationship Studies (S-SAR) of Tetrahydrolipstatin
|
|
February 2018 |
An Expeditious Enantioselective Total Synthesis of Valilactone
|
|
June 2006 |
Regioselective Carbonylation of trans -Disubstituted Epoxides to β-Lactones: A Viable Entry into syn -Aldol-Type Products
|
|
July 2013 |
Total Synthesis of Tetrahydrolipstatin and Stereoisomers via a Highly Regio- and Diastereoselective Carbonylation of Epoxyhomoallylic Alcohols
|
|
July 2014 |
The Asymmetric Synthesis of Tetrahydrolipstatin
|
|
August 2015 |
β-Lactams and β-lactones as activity-based probes in chemical biology
|
|
January 2012 |
Targeting Lipid Esterases in Mycobacteria Grown Under Different Physiological Conditions Using Activity-based Profiling with Tetrahydrolipstatin (THL)
|
|
December 2013 |
Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay
|
|
January 2015 |
Human lysosomal acid lipase inhibitor lalistat impairs Mycobacterium tuberculosis growth by targeting bacterial hydrolases
|
|
January 2016 |
Activity-Based Proteome Profiling of Potential Cellular Targets of Orlistat − An FDA-Approved Drug with Anti-Tumor Activities
|
|
December 2009 |
An Antibacterial β-Lactone Kills Mycobacterium tuberculosis by Disrupting Mycolic Acid Biosynthesis
|
|
December 2017 |
Synthesis and biological investigation of the β-thiolactone and β-lactam analogs of tetrahydrolipstatin
|
|
January 2012 |
Stereoselectivity and Regioselectivity in the Segment-Coupling Prins Cyclization
|
|
June 2001 |
A Readily Synthesized and Highly Active Epoxide Carbonylation Catalyst Based on a Chromium Porphyrin Framework: Expanding the Range of Available β-Lactones
|
|
February 2004 |
Enantiodivergent Synthesis of Both Enantiomers of Sulcatol and Matsutake Alcohol from ( R )-Epichlorohydrin
|
|
October 1987 |
The Intramolecular Asymmetric Pauson−Khand Cyclization as a Novel and General Stereoselective Route to Benzindene Prostacyclins: Synthesis of UT-15 (Treprostinil)
|
|
February 2004 |
Vanadium-catalyzed epoxidations. 2. Highly stereoselective epoxidations of acyclic homoallylic alcohols predicted by a detailed transition-state model
|
|
December 1981 |
In Situ Generation of the Coates Catalyst: A Practical and Versatile Catalytic System for the Carbonylation of meso -Epoxides
|
|
May 2011 |
Total synthesis of (-)-tetrahydrolipstatin
|
|
December 1993 |
Diastereoselective allylations and crotylations under phase-transfer conditions using trifluoroborate salts: an application to the total synthesis of (−)-tetrahydrolipstatin
|
|
October 2003 |
Radical Reaction of Sodium Hypophosphite with Terminal Alkynes: Synthesis of 1,1-Bis- H -phosphinates
|
|
December 2005 |
Effects of Lipid-Lowering Drugs on Vancomycin Susceptibility of Mycobacteria
|
|
August 2016 |
To catch a killer. What can mycobacterial models teach us about Mycobacterium tuberculosis pathogenesis?
|
|
February 2010 |
Genome-wide Phenotypic Profiling Identifies and Categorizes Genes Required for Mycobacterial Low Iron Fitness
|
|
August 2019 |
High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol Catabolism
|
|
September 2011 |
Global Assessment of Genomic Regions Required for Growth in Mycobacterium tuberculosis
|
|
September 2012 |
Characterization of Two New Multidrug-Resistant Strains of Mycobacterium smegmatis: Tools for Routine In Vitro Screening of Novel Anti-Mycobacterial Agents
|
|
January 2019 |
Rel Is Required for Morphogenesis of Resting Cells in Mycobacterium smegmatis
|
|
August 2016 |
Features of the biochemistry of Mycobacterium smegmatis, as a possible model for Mycobacterium tuberculosis
|
|
September 2020 |
Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis
|
|
June 2007 |
Laboratory Maintenance of Mycobacterium smegmatis
|
|
August 2009 |
Mycobacterium tuberculosis Strains H37ra and H37rv have equivalent minimum inhibitory concentrations to most antituberculosis drugs
|
|
January 2018 |
Genetic Basis of Virulence Attenuation Revealed by Comparative Genomic Analysis of Mycobacterium tuberculosis Strain H37Ra versus H37Rv
|
|
June 2008 |
Comparative proteomic analysis of Mycobacterium tuberculosis strain H37Rv versus H37Ra
|
|
December 2013 |
Determination of in vitro synergy between linezolid and other antimicrobial agents against Mycobacterium tuberculosis isolates
|
|
December 2015 |
Multidrug Resistance of a Porin Deletion Mutant of Mycobacterium smegmatis
|
|
November 2004 |
Genetic characterization of mycobacterial l,d-transpeptidases
|
|
August 2014 |
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
|
|
December 1995 |
Efflux Pump-Mediated Intrinsic Drug Resistance in Mycobacterium smegmatis
|
|
July 2004 |
The Discovery of 2-Aminobenzimidazoles That Sensitize Mycobacterium smegmatis and M. tuberculosis to β-Lactam Antibiotics in a Pattern Distinct from β-Lactamase Inhibitors
|
|
March 2017 |
Synergistic Drug Combinations for Tuberculosis Therapy Identified by a Novel High-Throughput Screen
|
|
May 2011 |
A rapid and non-pathogenic assay for association of Mycobacterium tuberculosis gyrBA mutations and fluoroquinolone resistance using recombinant Mycobacterium smegmatis
|
|
November 2018 |
Increased Vancomycin Susceptibility in Mycobacteria: a New Approach To Identify Synergistic Activity against Multidrug-Resistant Mycobacteria
|
|
June 2015 |
Use of Mycobacterium smegmatis Deficient in ADP-Ribosyltransferase as Surrogate for Mycobacterium tuberculosis in Drug Testing and Mutation Analysis
|
|
April 2015 |
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium.
|
|
May 1997 |
Molecular Basis of Intrinsic Macrolide Resistance in the Mycobacterium tuberculosis Complex
|
|
January 2004 |
Rifampin- or Capreomycin-Induced Remodeling of the Mycobacterium smegmatis Mycolic Acid Layer Is Mitigated in Synergistic Combinations with Cationic Antimicrobial Peptides
|
|
August 2018 |
AsnB Is Involved in Natural Resistance of Mycobacterium smegmatis to Multiple Drugs
|
|
January 2006 |
Molecular basis of clarithromycin activity against Mycobacterium avium and Mycobacterium smegmatis
|
|
February 1998 |
Reproducibility of the microdilution checkerboard method for antibiotic synergy
|
|
March 1993 |
Combination approaches to combat multidrug-resistant bacteria
|
|
March 2013 |
Requirement of the mymA Operon for Appropriate Cell Wall Ultrastructure and Persistence of Mycobacterium tuberculosis in the Spleens of Guinea Pigs
|
|
June 2005 |
Drug-Resistant Tuberculosis 2020: Where We Stand
|
|
March 2020 |
Characterization of tetracycline resistance mediated by the efflux pump Tap from Mycobacterium fortuitum
|
|
February 2006 |
Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives
|
|
March 2017 |
New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria
|
|
April 2017 |
Potency of vancomycin against Mycobacterium tuberculosis in the hollow fiber system model
|
|
March 2021 |
Bacterial resistance to antibiotics: Enzymatic degradation and modification
|
|
July 2005 |
Recent updates on drug resistance in Mycobacterium tuberculosis
|
|
October 2019 |
Look and Outlook on Enzyme-Mediated Macrolide Resistance
|
|
August 2018 |
Inactivation of fusidic acid by resistant Streptomyces strains.
|
|
January 1991 |
Purification and properties of the Mycobacterium smegmatis mc2155 β-lactamase
|
|
April 1997 |
Genetic analysis of the β-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to β-lactam antibiotics
|
|
February 2005 |
Inactivation of Mycobacterium tuberculosis l,d-Transpeptidase Ldt Mt1 by Carbapenems and Cephalosporins
|
|
May 2012 |
Fluorometric substrate for sulfatase and lipase
|
|
December 1969 |
Phaser crystallographic software
|
|
July 2007 |
Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method
|
|
November 2013 |
Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen
|
|
November 2013 |
DIALS : implementation and evaluation of a new integration package
|
|
February 2018 |
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
|
January 2010 |
electronic Ligand Builder and Optimization Workbench ( eLBOW ): a tool for ligand coordinate and restraint generation
|
|
September 2009 |
Features and development of Coot
|
|
March 2010 |